Gout patients who have taken the drug Uloric are at an increased risk of cardiovascular damage, heart attack, stroke, and heart-related death.
Uloric (Febuxostat) is a drug developed by Takeda Pharmaceuticals to treat the build up of excess uric acid, the primary symptom of gout. The FDA originally approved Uloric in 2009, with a warning about possibly fatal heart-related events and a requirement that Takeda continue to study the drug’s effect on cardiovascular safety. The subsequent trial, as reported in the New England Journal of Medicine, documented an increased risk of cardiovascular death among the 6,000 patients studied. The study compared patients who took Uloric to patients who were given allopurinol, a generic gout drug that had been on the market for decades.
GOUT CAN AFFECT ANYONE.
Gout, a condition related to arthritis, is the severely painful build-up of uric acid levels in the blood, which causes redness and swelling in one or more joints. The symptoms most often appear suddenly and include intense joint pain, inflammation and redness, limited range of motion, and discomfort in the affected joint that persists up to a few weeks.
Since its introduction in the 1960s, the primary uric acid reduction drug has been allopurinol. Uloric was developed and is prescribed for patients who either cannot take allopurinol or for whom allopurinol no longer works. The warnings now in place for Uloric state clearly that it may not be prescribed unless the generic doesn’t work.
With the increased risks for serious cardiovascular events, the FDA recommends that Uloric never be the first-line therapy for patients with gout.
TAKEDA WHISTLEBLOWER LAWSUIT BROUGHT THE ULORIC RISKS TO LIGHT.
A lawsuit filed in 2010 alleged that Takeda Pharmaceutical intentionally hid information about Uloric’s potentially dangerous side effects. A safety consultant for the company claimed that Takeda knew about the serious side effects and failed to warn consumers adequately or revise the product labelling.
Have you taken Uloric?
If you or a loved one has taken Uloric (Febuxostat) for gout and have suffered a cardiovascular event such as:
- Heart Attack
- Blood Clots
- Angina (chest pain)
you may be eligible for compensation.
Give us a call.
Call Davis & Crump for a free claim evaluation. We are experienced in defective drug litigations and settlements. Consult with us today about your potential claim without cost or obligation. Our firm advances all costs associated with your case, so there is no fee unless we make a successful recovery for you. With over 70 years of combined experience, our firm pursues a successful conclusion to each and every case.
Fill out at free claim evaluation or call us at 1-800-277-0300 to get started.
Fill out a free claim evaluation or call us at 1-800-277-0300 to get started.